What's in Navrongo Health Research Centre, Ghana's pipeline?

Navrongo Health Research Centre, Ghana has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Navrongo Health Research Centre, Ghana's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/navrongo-health-research-centre-ghana.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Navrongo Health Research Centre, Ghana — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Navrongo Health Research Centre, Ghana pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Artemether-lumefantrine combination plus albendazole	Artemether-lumefantrine combination plus albendazole	marketed	Antimalarial combination with anthelmintic	Plasmodium falciparum (multiple mechanisms); Ascaris, Hookworm, Trichuris (tubulin)	Infectious Disease
Albendazole plus Praziquantel	Albendazole plus Praziquantel	marketed	Antihelmintic combination	β-tubulin (albendazole); calcium channels (praziquantel)	Infectious Disease / Parasitology

Therapeutic area mix

Infectious Disease · 1
Infectious Disease / Parasitology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Navrongo Health Research Centre, Ghana:

Cite this brief

Drug Landscape (2026). Navrongo Health Research Centre, Ghana — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/navrongo-health-research-centre-ghana. Accessed 2026-05-17.